MRK — Merck & Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	8-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	48,704	59,283	60,115	64,168	65,011
Cost of Revenue
Gross Profit	35,463	42,077	44,200	49,470	52,984
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	36,166	41,338	58,333	44,256	43,790
Operating Profit	12,538	17,945	1,783	19,912	21,221
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13,879	16,444	1,889	19,936	21,067
Provision for Income Taxes
Net Income After Taxes	12,358	14,526	377	17,133	18,263
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	13,049	14,519	365	17,117	18,254
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	13,049	14,519	365	17,117	18,254
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.71	7.3	5.73	9.06	9.89
Dividends per Share